The basics: what happens in pancreatic cancer

Pancreatic cancer begins when cells in the pancreas grow abnormally and form a tumor. The pancreas is a gland about the size of your hand, tucked behind your stomach. It does two main jobs: it makes digestive enzymes that break down food, and it produces hormones—including insulin—that control blood sugar. When cancer develops, the abnormal cells multiply and can spread to nearby organs or travel through the bloodstream to distant parts of the body.

Most pancreatic cancers are adenocarcinomas, which start in the cells that line the ducts carrying digestive enzymes. These tumors typically grow in the head of the pancreas, the wider part closest to the small intestine. Because the pancreas sits deep inside the abdomen, tumors often grow for a while before causing noticeable symptoms, which is why pancreatic cancer is frequently diagnosed at a later stage.

The disease is serious because pancreatic cancer cells tend to spread quickly and resist treatment. However, survival rates and treatment options have improved in recent years, and the outlook depends on factors like the stage at diagnosis, the person's overall health, and how the cancer responds to treatment.

Key Takeaways

  • Pancreatic cancer starts when cells in the pancreas grow abnormally; most cases are adenocarcinomas that begin in the ducts.
  • The pancreas sits deep in the abdomen, so tumors often grow without causing symptoms until the cancer is more advanced.
  • Risk factors include smoking, chronic pancreatitis, family history of pancreatic cancer, and certain genetic conditions.
  • Common symptoms include abdominal or back pain, yellowing of the skin or eyes, digestive problems, and unexplained weight loss.
  • Diagnosis involves imaging tests like CT or MRI scans, blood tests, and sometimes a biopsy to confirm cancer cells.

Risk factors that increase your chances

Smoking is the strongest modifiable risk factor—smokers have roughly two to three times the risk of nonsmokers. Chronic pancreatitis, long-term inflammation of the pancreas, also raises risk significantly. People with a family history of pancreatic cancer, especially if a parent or sibling was diagnosed before age 50, face higher odds.

Certain inherited genetic conditions increase risk substantially. These include BRCA1 and BRCA2 mutations (also linked to breast and ovarian cancer), Lynch syndrome, and familial adenomatous polyposis (FAP). People with hereditary pancreatitis—a rare condition causing repeated inflammation—also have elevated risk.

Other factors include obesity, type 2 diabetes (especially if diagnosed recently), cirrhosis of the liver, and certain occupational exposures. Age matters too: pancreatic cancer is rare before age 45 and becomes more common with each decade after 50. Having one or more risk factors does not mean you will develop cancer, but it may warrant discussion with your doctor about screening or monitoring.

Symptoms and when they appear

Early pancreatic cancer often causes no symptoms, which is why it is frequently found at a later stage. When symptoms do appear, they can include abdominal pain (usually in the upper middle or upper left), back pain between the shoulder blades, and jaundice—yellowing of the skin and whites of the eyes caused by a buildup of bile.

Digestive symptoms are common: nausea, loss of appetite, weight loss without trying, and pale or clay-colored stools. Some people notice their urine becomes dark. New-onset diabetes can also be a sign, because cancer in the pancreas can interfere with insulin production. These symptoms can have many other causes, but they warrant a conversation with your doctor, especially if they persist for more than a few weeks.

The location of the tumor affects which symptoms appear first. Tumors in the head of the pancreas often block the bile duct early, causing jaundice. Tumors in the body or tail may grow larger before causing symptoms, which is one reason they are sometimes diagnosed later.

How pancreatic cancer is diagnosed

Diagnosis usually starts with imaging. A CT scan or MRI creates detailed pictures of the pancreas and surrounding organs, allowing doctors to spot tumors and see whether cancer has spread. Endoscopic ultrasound (EUS) uses a thin tube with a camera and ultrasound probe to get close-up images and can also obtain a tissue sample.

Blood tests measure levels of a protein called CA 19-9, which is often elevated in pancreatic cancer. This test alone cannot diagnose cancer—many benign conditions raise CA 19-9—but it helps doctors track the disease and monitor treatment response. A biopsy, in which a small sample of tissue is removed and examined under a microscope, confirms whether cancer cells are present.

Once cancer is confirmed, additional tests determine the stage—how far it has spread. Staging guides treatment decisions and helps doctors estimate prognosis. Stages range from 1 (cancer confined to the pancreas) to 4 (cancer has spread to distant organs). Genetic testing may also be recommended, especially if you have a family history, because results can affect treatment options and inform screening for relatives.

Types of pancreatic cancer

Adenocarcinoma accounts for about 85% of pancreatic cancers and starts in the cells lining the ducts. Squamous cell carcinoma and adenosquamous carcinoma are rarer types that also begin in the ducts but behave differently. Acinar cell carcinoma starts in the cells that produce digestive enzymes and tends to grow more slowly than ductal adenocarcinoma.

Neuroendocrine tumors (NETs) arise from hormone-producing cells and are less common than adenocarcinoma. They sometimes grow slowly and may be discovered incidentally on imaging done for other reasons. Cystic tumors are fluid-filled growths that may or may not be cancerous; some are monitored rather than removed immediately.

The type of cancer affects treatment options and outlook. Your pathology report will specify which type you have, and your oncologist will use that information along with stage and genetic findings to recommend a treatment plan tailored to your situation.

How pancreatic cancer spreads

Pancreatic cancer can spread in three ways: directly into nearby tissues and organs, through the lymph nodes (small glands that filter fluid), or through the bloodstream to distant sites. Because the pancreas sits near the stomach, small intestine, liver, and spleen, tumors in the head often invade these organs. Tumors in the body or tail may reach the left kidney or colon.

The lymph nodes around the pancreas are usually affected early. Cancer cells can travel through lymphatic vessels to nodes in the abdomen and chest. Distant spread, called metastasis, most commonly occurs in the liver, lungs, and peritoneum (the lining of the abdominal cavity). Bone and brain involvement is less common but possible.

The extent of spread is one of the most important factors in determining treatment options. Cancers that have not spread beyond the pancreas may be removed surgically, while cancers that have spread to distant organs are typically treated with chemotherapy or other systemic therapies designed to reach cancer cells throughout the body.

Survival rates and what they mean

Pancreatic cancer has a lower five-year survival rate than many other cancers, but this varies significantly by stage at diagnosis. People diagnosed with stage 1 cancer (confined to the pancreas) have substantially better outcomes than those diagnosed with stage 4 (spread to distant organs). Survival also depends on age, overall health, whether surgery is possible, and how the cancer responds to treatment.

Survival statistics are based on large groups of people and cannot predict any individual's outcome. A person diagnosed today may have access to newer treatments not included in older statistics. Advances in chemotherapy combinations, targeted therapies, and immunotherapy have improved outcomes for some patients in recent years. Your oncologist can discuss what the statistics mean for your specific situation based on your cancer's characteristics and your health.

Survival rates are one piece of information, not a prediction. Many people live longer than statistics suggest, and quality of life during and after treatment is also important to consider when making decisions about care.

Frequently Asked Questions

Is pancreatic cancer always fatal?

No. While pancreatic cancer is serious and has lower survival rates than some other cancers, people do survive it, especially when diagnosed early or when the cancer responds well to treatment. Outcomes have improved with newer therapies, and some people live for years after diagnosis.

Can pancreatic cancer run in families?

Yes. If multiple family members have had pancreatic cancer, or if you carry a gene mutation like BRCA1, BRCA2, or Lynch syndrome, your risk is higher. Genetic counseling can help determine whether testing makes sense for you and your relatives.

What is the difference between pancreatic cancer and pancreatitis?

Pancreatitis is inflammation of the pancreas, usually caused by gallstones or alcohol. Pancreatic cancer is a malignant tumor. Chronic pancreatitis increases the risk of developing cancer, but the two are distinct conditions with different treatments.

Can you survive pancreatic cancer without surgery?

Yes. Not all pancreatic cancers can be removed surgically—some have spread too far or are in locations that make surgery too risky. Chemotherapy, radiation, targeted therapy, and immunotherapy can be used alone or in combination to treat cancer that cannot be operated on.

What should I do if someone in my family had pancreatic cancer?

Talk to your doctor about your family history. Depending on how closely you are related and the age at diagnosis, your doctor may recommend genetic testing, more frequent screening, or simply increased awareness of symptoms. Not everyone with a family history will develop cancer.